Targeting fatty acid synthase in preclinical models of TNBC brain metastases synergizes with SN-38 and impairs invasion
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Targeting fatty acid synthase in preclinical models of TNBC brain metastases synergizes with SN-38 and impairs invasion ; volume:10 ; number:1 ; day:10 ; month:6 ; year:2024 ; pages:1-7 ; date:12.2024
npj Breast cancer ; 10, Heft 1 (10.6.2024), 1-7, 12.2024
- Urheber
-
Serhan, Habib A.
Bao, Liwei
Cheng, Xu
Qin, Zhaoping
Liu, Chia-Jen
Heth, Jason A.
Udager, Aaron M.
Soellner, Matthew B.
Merajver, Sofia D.
Morikawa, Aki
Merrill, Nathan M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41523-024-00656-0
- URN
-
urn:nbn:de:101:1-2408162221438.046073633587
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Serhan, Habib A.
- Bao, Liwei
- Cheng, Xu
- Qin, Zhaoping
- Liu, Chia-Jen
- Heth, Jason A.
- Udager, Aaron M.
- Soellner, Matthew B.
- Merajver, Sofia D.
- Morikawa, Aki
- Merrill, Nathan M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
RSPO3 impairs barrier function of human vascular endothelial monolayers and synergizes with pro-inflammatory IL-1
BCL-XL PROTAC degrader DT2216 synergizes with sotorasib in preclinical models of KRASG12C-mutated cancers
PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway
Compound Absorption in Polymer Devices Impairs the Translatability of Preclinical Safety Assessments
Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase
Loss of glucosylceramide synthase impairs the growth and virulence of Fusarium oxysporum f. sp. cubense
CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems
Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs
EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis
Unrevealing the Role of miRNA in Successful TNBC Treatment: A Pilot Study to Explore the Chemotherapy Drugs for Timely Treatment of TNBC
The Potential of PSMA as a Vascular Target in TNBC
FZD5 contributes to TNBC proliferation, DNA damage repair and stemness
RSPO3 impairs barrier function of human vascular endothelial monolayers and synergizes with pro-inflammatory IL-1
BCL-XL PROTAC degrader DT2216 synergizes with sotorasib in preclinical models of KRASG12C-mutated cancers
PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway
Compound Absorption in Polymer Devices Impairs the Translatability of Preclinical Safety Assessments
Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase
Loss of glucosylceramide synthase impairs the growth and virulence of Fusarium oxysporum f. sp. cubense
CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems
Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs
EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis
Unrevealing the Role of miRNA in Successful TNBC Treatment: A Pilot Study to Explore the Chemotherapy Drugs for Timely Treatment of TNBC
The Potential of PSMA as a Vascular Target in TNBC
FZD5 contributes to TNBC proliferation, DNA damage repair and stemness
RSPO3 impairs barrier function of human vascular endothelial monolayers and synergizes with pro-inflammatory IL-1
BCL-XL PROTAC degrader DT2216 synergizes with sotorasib in preclinical models of KRASG12C-mutated cancers
PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway
Compound Absorption in Polymer Devices Impairs the Translatability of Preclinical Safety Assessments
Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase
Loss of glucosylceramide synthase impairs the growth and virulence of Fusarium oxysporum f. sp. cubense
CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems
Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs
EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis
Unrevealing the Role of miRNA in Successful TNBC Treatment: A Pilot Study to Explore the Chemotherapy Drugs for Timely Treatment of TNBC
The Potential of PSMA as a Vascular Target in TNBC